Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Since its founding in 2001, GNI has evolved from a basic research idea on gene-networks to a fully-fledged young pharmaceutical company listed on the Mothers Board of the Tokyo Stock Exchange. Our company has also grown from a small team of young scientists to a group of affiliated companies with operation campuses in Tokyo, Beijing, and Shanghai, which represent the 2nd and 3rd largest economies in the world. Most importantly...
Since its founding in 2001, GNI has evolved from a basic research idea on gene-networks to a fully-fledged young pharmaceutical company listed on the Mothers Board of the Tokyo Stock Exchange. Our company has also grown from a small team of young scientists to a group of affiliated companies with operation campuses in Tokyo, Beijing, and Shanghai, which represent the 2nd and 3rd largest economies in the world. Most importantly, GNI Group managed to have its own drug producing factory in a prime location which is very rare among our peers. Life sciences are the hopes for millions of patients suffering from thousands of types of diseases.

List your booth number for exhibitions, ask us